2BB score and signals
Viking Therapeutics, Inc.’s current 2BB score is 48 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 57 | Moderate |
| Momentum | 53 | Stable |
| Financial strength | 13 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 44 | Moderate |
Company facts
| CEO | Brian Lian |
| Founded | 2012 |
| Employees | 65 |
| 52-week range | $25.28 – $43.15 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-09 | — | -1.1225 | — | $0.00 |
| 2026-10-28 | — | -1.0918 | — | $0.00 |
| 2026-07-29 | — | -1.272 | — | $0.00 |
| 2026-04-29 | -1.37 | -1.0343 | $0.00 | $0.00 |
Related companies
2BBBullish & Bearish